Medical Net, Inc. (3645.T)
JPY 292.0
(1.04%)
JPY 292.0
(1.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 119.58 Million | 429.13 Million | 342.55 Million | 391.86 Million | 78.29 Million |
| Net Income | 5.95 Million | 250.74 Million | 533.77 Million | 254.08 Million | 103.97 Million |
| Depreciation & Amortization | 53.81 Million | 62.07 Million | 35.06 Million | 24.85 Million | 20.66 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -63.82 Million | 58.73 Million | 11.67 Million | 68.09 Million | -27.73 Million |
| Other non-cash items | 334.57 Million | 83.31 Million | -67.96 Million | -12.65 Million | -10.93 Million |
| Investing Cash Flow | -285.4 Million | -62.36 Million | -355.11 Million | -87.98 Million | -14.6 Million |
| Investments in PPE | -32.79 Million | -20.63 Million | -2.16 Million | -13.02 Million | -8.73 Million |
| Acquisitions | -218.44 Million | 3.78 Million | -340.63 Million | -48.69 Million | - |
| Investment purchases | -14.16 Million | -40.04 Million | -54.26 Million | -38.87 Million | -18.51 Million |
| Sales/Maturities of investments | - | - | 40.53 Million | 9.37 Million | 13.6 Million |
| Other Investing Activities | -20 Million | -9.79 Million | -1.92 Million | -2.06 Million | -4.22 Million |
| Financing Cash Flow | 144.1 Million | -17.9 Million | 282.23 Million | -34.03 Million | -497.4 Million |
| Debt repayment | -172.79 Million | -17.03 Million | -315.41 Million | -27.87 Million | -319.86 Million |
| Dividends payments | -22.49 Million | -35.17 Million | -34.22 Million | -6.15 Million | -10.84 Million |
| Common Stock Repurchased | - | - | - | - | -796.46 Million |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -2000.00 | 239 Thousand | 1.04 Million | -110 Million | -9.96 Million |
| Accounts receivables | -115.95 Million | -30 Million | -44 Million | -27 Million | -1 Million |
| Accounts payables | 85.09 Million | 63.12 Million | 10.62 Million | 4.95 Million | -18.25 Million |
| Inventory | -72.45 Million | 5.02 Million | -28.77 Million | -1.46 Million | -5.39 Million |
| Other working capital | 39.48 Million | 58 Million | -18 Million | 19 Million | -3 Million |
| Cash at beginning of period | 1.51 Billion | 1.12 Billion | 868.66 Million | 595.89 Million | 1.02 Billion |
| Cash at end of period | 1.5 Billion | 1.51 Billion | 1.12 Billion | 868.66 Million | 595.89 Million |
| Capital Expenditure | -32.79 Million | -20.63 Million | -2.16 Million | -13.02 Million | -8.73 Million |
| Effect of forex changes on cash | 16.07 Million | 35.69 Million | -9.54 Million | 2.92 Million | 650 Thousand |
| Net cash flow / Change in cash | -5.63 Million | 384.56 Million | 260.12 Million | 272.76 Million | -433.05 Million |
| Free Cash Flow | 86.78 Million | 408.5 Million | 340.38 Million | 378.84 Million | 69.55 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -41 Million | 5.95 Million | -69 Million | 94 Million | 21 Million | 250.74 Million |
| Depreciation & Amortization | - | 53.81 Million | - | - | - | 62.07 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -63.82 Million | - | - | - | 58.73 Million |
| Other non-cash items | 41 Million | 334.57 Million | 69 Million | -94 Million | -21 Million | 83.31 Million |
| Investing Cash Flow | - | -285.4 Million | - | - | - | -62.36 Million |
| Investments in PPE | - | -32.79 Million | - | - | - | -20.63 Million |
| Acquisitions | - | -218.44 Million | - | - | - | 3.78 Million |
| Investment purchases | - | -14.16 Million | - | - | - | -40.04 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -20 Million | - | - | - | -9.79 Million |
| Financing Cash Flow | - | 144.1 Million | - | - | - | -17.9 Million |
| Debt repayment | - | -172.79 Million | - | - | - | -17.03 Million |
| Dividends payments | - | -22.49 Million | - | - | - | -35.17 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -2000.00 | - | - | - | 239 Thousand |
| Accounts receivables | - | -115.95 Million | - | - | - | -30 Million |
| Accounts payables | - | 85.09 Million | - | - | - | 63.12 Million |
| Inventory | - | -72.45 Million | - | - | - | 5.02 Million |
| Other working capital | - | 39.48 Million | - | - | - | 58 Million |
| Cash at beginning of period | - | 1.51 Billion | - | - | - | 1.12 Billion |
| Cash at end of period | - | 1.5 Billion | - | - | - | 1.51 Billion |
| Capital Expenditure | - | -32.79 Million | - | - | - | -20.63 Million |
| Effect of forex changes on cash | - | 16.07 Million | - | - | - | 35.69 Million |
| Net cash flow / Change in cash | - | -5.63 Million | - | - | - | 384.56 Million |
| Free Cash Flow | - | 86.78 Million | - | - | - | 408.5 Million |
CAI
HRUM
6238
9254
FCL
6235